Navigation Links
Centiva/5

ProductsCentiva/5
Company Datex-Ohmeda, Inc.
Item Centiva/5
Features 
  • Seven modes of ventilation plus an apnea ventilation backup.
  • Airway resistance compensation.
  • Non-invasive ventilation.
  • Compliance and resistance compensation.
  • Automatic patient detection.
  • Automatic suction routine.
  • Alarm Autoset.
  • The Centiva/5 is also a member of the Datex-Ohmeda System/5 family of products.
  • The Centiva/5 is not just a ventilator its a versatile partner designed with your needs and work environment in mind.
  • Description Performance beyond your investment.

    The Centiva/5 Critical Care Ventilator is your solution to the space and time demands of the critical care environment. The Centiva has been designed with the clinician in mind combining a compact size with high levels of performance. The Centivas small size opens up valuable space around the patients bed and allows you the freedom to mount the entire system on the wall or remote mount the display unit while the ventilator engine is strategically placed out of the clinicians way.

    Special attention was placed on simplifying the operation of the Centiva. Its controls and menus are based on the well-established Datex-Ohmeda user interface making it easy to navigate which helps shorten the learning curve for new users. The Centiva is equipped for fast, easy turn around having only three parts that need cleaning in between patient uses.

    While the Centiva/5 boasts a small size, its level of performance is anything but small.

    Please contact your local Datex-Ohmeda Distributor for availability in your country.
    Info Datex-Ohmeda, Inc.
    Customer Service: (800) 345-2700
    Web site: http://www.us.datex-ohmeda.com/index.asp

    Related medicine products :

    1. Optilene Mesh Elastic - Eleastic lightweight and large pore mesh
    ... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
    ... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
    ... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
    ... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
    Medicine Products:
    (Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
    (Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
    (Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
    Breaking Medicine News(10 mins):
    (Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
    (Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
    (Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
    Breaking Medicine Technology: